---
title: "12 Health Care Stocks Moving In Friday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289644239.md"
description: "In Friday's after-market session, several healthcare stocks saw significant movement. Gainers included Aspire Biopharma (+23.2%), Innate Pharma (+19.31%), and Aditxt (+12.59%). Conversely, losers featured Cuprina Holdings (-9.4%), Zhengye Biotechnology (-8.6%), and Adial Pharmaceuticals (-6.72%). The report highlights specific price changes and market capitalizations for these companies."
datetime: "2026-06-12T21:05:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289644239.md)
  - [en](https://longbridge.com/en/news/289644239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289644239.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's After-Market Session

### Gainers

-   **Aspire Biopharma Holdings** (NASDAQ:ASBP) stock moved upwards by 23.2% to $6.11 during Friday's after-market session. The market value of their outstanding shares is at $7.7 million.
-   **Innate Pharma** (NASDAQ:IPHA) stock moved upwards by 19.31% to $2.1. The market value of their outstanding shares is at $163.2 million.
-   **Aditxt** (NASDAQ:ADTX) shares increased by 12.59% to $0.01.
-   **Retractable Technologies** (AMEX:RVP) shares rose 7.97% to $0.76. The market value of their outstanding shares is at $20.9 million.
-   **Aytu BioPharma** (NASDAQ:AYTU) shares increased by 7.44% to $2.31. The market value of their outstanding shares is at $23.5 million.
-   **XORTX Therapeutics** (NASDAQ:XRTX) shares rose 7.33% to $2.34. The market value of their outstanding shares is at $3.7 million.

### Losers

-   **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) shares fell 9.4% to $3.6 during Friday's after-market session. The company's market cap stands at $6.4 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares declined by 8.6% to $0.75. The market value of their outstanding shares is at $42.6 million.
-   **Adial Pharmaceuticals** (NASDAQ:ADIL) shares fell 6.72% to $2.78. The company's market cap stands at $6.3 million.
-   **Autonomix Medical** (NASDAQ:AMIX) shares decreased by 6.57% to $0.36. The market value of their outstanding shares is at $4.4 million.
-   **Theriva Biologics** (AMEX:TOVX) stock fell 6.42% to $0.28. The company's market cap stands at $14.0 million.
-   **GlucoTrack** (NASDAQ:GCTK) stock declined by 6.42% to $0.36. The market value of their outstanding shares is at $2.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md)
- [ADIL.US](https://longbridge.com/en/quote/ADIL.US.md)
- [IPHA.US](https://longbridge.com/en/quote/IPHA.US.md)
- [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [RVP.US](https://longbridge.com/en/quote/RVP.US.md)
- [AYTU.US](https://longbridge.com/en/quote/AYTU.US.md)
- [XRTX.US](https://longbridge.com/en/quote/XRTX.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [TOVX.US](https://longbridge.com/en/quote/TOVX.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md)

## Related News & Research

- [Vaxcyte management to join Wells Fargo healthcare conference fireside chat](https://longbridge.com/en/news/297227027.md)
- [Piper Sandler Sticks to Its Hold Rating for Agilent (A)](https://longbridge.com/en/news/297181196.md)
- [Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement | PFSA Stock News](https://longbridge.com/en/news/297520570.md)
- [Attovia Therapeutics, Inc. (ATTO) Initiated with a Buy at RBC Capital](https://longbridge.com/en/news/297470988.md)
- [Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market (NASDAQ: ENTX)](https://longbridge.com/en/news/297523539.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**